08:42 AM EDT, 10/21/2024 (MT Newswires) -- VSee Health ( VSEE ) said Monday it expanded its telehealth service offering by launching a new specialized program that will integrate GLP-1 prescription medicines within its existing offerings and is designed to address obesity and related health risks.

The GLP-1 initiative will combine telehealth access, prescription drug support and behavioral intervention, with participants set to receive personalized care plans, virtual support calls and access to GLP-1 medicines. The program provides subscriptions at $4.99 a month, VSee said.

Shares of the company were up 26% in recent Monday premarket activity.

Price: 2.0700, Change: +0.43, Percent Change: +26.22